Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Noramco
Noramco
Activities:
Manufacturing
Ingredients
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part I
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Effective ways to optimise heat exchangers
Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Upcoming event
Lounges
23-25 April 2024 | Conference | Messe Karlsruhe, Germany
See all
Related Content
Noramco announces strategic alignment with Purisys and Halo Pharma
The three organisations will provide North American supply chain solutions for clinical and commercial APIs and drug products
Manufacturing
Nemus finds US supplier for CBD-based retinal disease therapy
Controlled substance producer Noramco has been chosen to produce and scale up the new treatment
Ingredients
Noramco announces provisional patent application of proprietary cannabidiol (CBD)
Filing with the US Patent and Trademark Office covers pure cannabidiol compositions
Manufacturing
Development of patient friendly formulations agreement signed
Noramco and SPI Pharma have signed an agreement to develop and license a set of value-added formulation packages for global pharmaceutical manufacturers of finished dosage forms
Ingredients
Business going forward for Normaco
Noramco, a global leader in the manufacture and supply of controlled substance active pharmaceutical ingredients announces major developments in its pharmaceutical offering at this year’s CPhI Worldwide
Ingredients
Noramco planning expansion in API market
Noramco will outline its business expansion plan at the Drug, Chemical and Associated Technologies Association (DCAT) meeting
Manufacturing
Aesica forms alliance with Noramco
For the manufacture of codeine
Subscribe now